BriaCell Therapeutics (BCT) Financial Statements

107 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently C$29.94M. The company's EPS TTM is C$-14.56; its P/E ratio is -0.56; BriaCell Therapeutics is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jul 25	Jul 24	Jul 23	Jul 22	Jul 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -147.89K	$ -114.04K	$ -20.49K	$ -19.39K	$ -19.44K
Operating Income	$ -37.73M	$ -46.02K	$ -23.27M	$ -15.29M	$ -6.97M
EBITDA	$ -36.63M	$ -45.91K	$ -27.23M	$ -34.05M	$ -6.95M
Net Income	$ -36.50M	$ -6.62K	$ -20.30M	$ -11.58M	$ -2.90M
Balance Sheet
Cash & Short-Term Investments	$ 17.87M	$ 862.09K	$ 21.25M	$ 41.04M	$ 57.27M
Total Assets	$ 21.65M	$ 5.87M	$ 27.16M	$ 42.58M	$ 58.04M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 25.99K
Net Debt	$ -10.49M	$ -862.09K	$ -21.25M	$ -41.04M	$ -57.24M
Total Liabilities	$ 4.32M	$ 8.56M	$ 30.94M	$ 32.25M	$ 782.24K
Stockholders' Equity	$ 24.72M	$ -2.38M	$ -3.78M	$ 10.33M	$ 57.26M
Cash Flow
Free Cash Flow	$ -28.17M	$ -24.58M	$ -23.74M	$ -12.48M	$ -7.75M
Operating Cash Flow	$ -28.17M	$ -24.13M	$ -23.74M	$ -12.48M	$ -7.75M
Investing Cash Flow	$ -7.65M	$ -681.80K	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 45.45M	$ 4.42M	$ 3.95M	$ -3.74M	$ 65.00M

Currency in USD

BriaCell Therapeutics Earnings and Revenue History

Income Statement >

BriaCell Therapeutics Debt to Assets

Balance Sheet >

BriaCell Therapeutics Cash Flow

Cash Flow >

BriaCell Therapeutics Forecast EPS vs Actual EPS

Earnings >